Advanced search
Publication Cover
Leukemia & Lymphoma Volume 43, 2002 - Issue 11
Submit an article Journal homepage
62
Views
54
CrossRef citations to date
0
Altmetric
Research Article

188 Re-labeled Anti-CD66 Monoclonal Antibody in Stem Cell Transplantation for Patients with High-risk Acute Myeloid Leukemia

Donald Bunjes Department of Hematology/Oncology, Ulm University Hospital, Robert-Koch-Strasse 8, 89081 Ulm, Germany
Pages 2125-2131 | Published online: 01 Jul 2009

  • Mayer, R., Davis, R., Schiffer, C., Berg, D., Powell, B., Schulman, p., Omura, G., Moore, J., McIntyre, O. and Frei, E. (1994) "Intensive postremission chemotherapy in adults with acute myeloid leukemia", New England Journal of Medicine 331, 896-903.
  • Grimwade, D., Walker, H., Oliver, F. Wheatley, K., Harrison, C., Harrison, G., Rees, J., Hann, I., Stevens, R., Burnett, A. and Goldstone, A. (1998) "The importance of diagnostic cytogenetics on outcome in AML: analysis of 1612 patients entered into the MRC AML 10 trial", Blood 92, 2322-2333.
  • Wheatley, K., Burnett, A., Goldstone, A., Gray, R., Hann, I., Harrison, C., Rees, J., Stevens, R. and Walker, H. (1999) "A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial", British Journal of Haematotogy 107, 69-79.
  • Mrozek, K., Heimonen, K., De la Chapelle, A. and Bloomfield, C. (1997) "Clinical significance of cytogenetics in acute myeloid leukemia", Seminars in Oncology 24, 17-31.
  • Anderson, J., Appelbaum, F., Schoch, G. and al, e. (1996) "Allogeneic bone marrow transplantation for myelodysplastic syndrome with advanced disease morphology: a phase II study of busulfan, cyclophosphamide and total body irradiation and analysis of risk factors", Journal of Clinical Oncology 14, 220-226.
  • Edenfield, W. and Gore, S. (1999) "Stage-specific application of allogencic and autologous marrow transplantation in the management of acute myeloid leukemia", Seminars in Oncology 26, 21-34.
  • Gale, R., Horowitz, M., Weiner, R., Ash, R., Atkinson, K., Babu, R., Dicke, K., Klein, J., Löwenberg, B., Reiffers, J., Rimm, A., Rowlings, P., Sandberg, A., Sobocinski, K., Veum-Stone, J. and Bortin, M. (1995) "Impact of cytogenetic abnormalities on outcome of bone marrow transplants in acute myelogenous leukemia in first remission", Bone Marrow Transplantation 16, 203-208.
  • Ferrant, A., Labopin, M., Frassoni, F., Prentice, H., Cahn, J., Blaise, D., Reiffers, J., Visani, G., Sanz, M., Boogaerts, M., Löwenberg, B. and Gorin, N. (1997) "Karyotype in acute myeloblastic leukemia: prognostic significance for bone marrow transplantation in first remission: a European Group for Blood and Marrow Transplantation study", Blood 90, 2931-2938.
  • Keating, S., Suciu, S., De Wine, T., Mandelli, F., Willemze, R., Resegotti, L., Broccia, G., Thaler, J., Damasto, E., Bizzi, B., Rotoli, B., Vekhoff, A., Muus, P., Petti, M., Durdenne, M., Vegna, M. and Zittoun, R. (1996) "Prognostic factors of patients with acute myeloid leukemia (AML) grafted in first complete remission: an analysis of the EORTC-GIMEMA AML 8A trial", Bone Marrow Transplantation 17, 993-1001.
  • Horowitz, M. (2000) "Results of allogeneic stem cell transplantation for malignant disorders", In: Hoffman, R., Benz, R., Shattil, S., Furie, B., Cohen, H., Silberstein, L. and McGlave, P. eds, Hematology. Basic Principles and Practice (Churchill Livingstone, USA), pp. 1573-1587.
  • Matthews, D., Appelbaum, F., Eary, J., Hui, T., Fisher, D., Martin, P., Durack, L., Nelp, W., Prss, O., Badger, C. and Bernstein, I. (1991) "Radiolabeled anti-CD45 monoclonal antibodies target lymphohematopoetic tissue in the macaque", Blood 78, 1864-1874.
  • Matthews, D., Badger, C., Fisher, D., Hui, T. Nourigat, C., Appelbaum, F., Martin, P. and Bernstein, I. (1992) "Selective radiation of hematolymphoid tissue delivered by anti-CD45 antibody", Cancer Research 52, 1228.
  • Van der Jagt, R., Badger, C., FR, A., Press, O., Matthews, D., Eary, J., Krohn, K. and Bernstein, I. (1992) "Localization of radiolabeled anti-myeloid antibodies in a human acute leukemia xenograft model", Cancer Research 52, 89.
  • Matthews, D., Appelbaum, F., Eary, J., Mitchell, D., Press, O. and Bernstein, I. (1996) "Targeted hematopoietic irradiation using 131-1-anti-CD45 antibody in patients with acute leukemia undergoing marrow transplantation", Proceedings of the American Association for Cancer Research 37, 627.
  • Jurcic, J., Caron, P., Nikula, T., Papadopoulos, E., Finn, R., Gansow, O., Miller, W., Geerlings, M., Warrel, R., Larson, S. and Scheinberg, D. (1995) "Radiolabeled anti-CD33 monoclonal antibody M195 for myeloid leukemias", Cancer Research 55(Suppl.). 5908a-5910a.
  • Matthews, D., Appelbaum, F., Eary, J., Fisher, D., Durack, L., Hui, T., Martin, P., Mitchell, D., Press, O., Storb, R. and Bernstein, I. (1999) "Phase I study of 131 1-anti CD45 antibody plus cyclophosphamide and total body irradiation for advanced acute leukemia and myelodysplastic syndrome", Blood 94, 1237-1247.
  • Noworolska, A., Hardoszjnska, A., Richter, R. and Brodzka, W. (1985) "Non-specific cross-reading antigen (NCA) in the individual maturation stages of myeloid cell series", British Journal of Cancer 51, 371-377.
  • Noworolska, A., Hardozinska, A., Buchegger, E. Lawinska, B. and Richter, R. (1989) "Expression of non-specific cross-reacting antigen species in myeloid leukemic patients and healthy subjects", Blut 58, 69-73.
  • Bordessoule, D. Jones, M., Gatter, K. and Mason, D. (1993) "Immunohistological patterns of myeloid antigens: tissue distribution of CD13, CD14, CD16, CD31, CD36, CD65, CD66 and CD67", British Journal of Haematology 83, 370-383.
  • Becker, W., Goldenberg, D. and Wolf, F. (1994) "The use of monoclonal antibodies and antibody fragments in the imaging of infectious lesions", Seminars in Nuclear Medicine 25, 1-13.
  • Reske, S. (1991) "Recent advances in bone marrow scanning", European Journal of Nuclear Medicine 18, 203-221.
  • Schubinger, P., Hasler, P., Novak-Hofer, I. and Bläuenstein, P. (1989) "Assessment of the binding properties of Granuloszint", European Journal of Nuclear Medicine 15, 605-608.
  • Press, O. Appelbaum, F., Kary, J. and Bernstein, I. (1995) "Radiolabeled antibody therapy of lymphomas", In: De Vita, V.T., Hellmann, S. and Rosenberg, S., eds, Important Advances in Oncology (Lippincott, USA), pp. 157-171.
  • Bunjes, D., Buchmann, I., Duncker, C., Seitz, U., Kotzerke, J., Wiesneth, M., Dohr, D., Stefanic, M., Buck, A., Von Harsdorf, S., Glatting, G., Grimminger, W., Karakas, T., Munzert, G., Dönner, H., Bergmann, L. and Reske, S. (2001) "188-Re labeled anti-CD66 (a,b,c,e) monoclonal antibody to intensify the conditioning regimen prior to stem cell transplantation for patients with high-risk acute myeloid leukemia or myelodysplastic syndrome: results of a phase I-II study", Blood 98, 565-572.
  • Knapp, F. and Mirzadeh, S. (1994) "The continuing important role of radionuclide generator systems for nuclear medicine", European Journal of Nuclear Medicine 20, 1151-1165.
  • Seitz, U., Neumaier, B., Glatting, G., Kotzerke, J., Bunjes, D. and Reske, S. (1999) "Preparation and evaluation of the rhenium-188-labelled anti-NCA antigen monoclonal antibody BW 250/183 for radioimmunotherapy of leukaemia", European Journal of Nuclear Medicine 26, 1265-1273.
  • Kotzerke, J., Glatting, G., Seitz, U., Rentschler, M., Neumaier, B., Bunjes, D., Duncker, C., Bergmann, L., Dohr, D. and Reske, S. (2000) "Radioimmunotherapy for the intensification of conditioning prior to stem cell transplantation: differences in dosimetry and biokinetics of Re-188 and Tc-99m-labeled monoclonal anti NCA-95 antibodies", Journal of Nuclear Medicine 41, 531-537.
  • Stabin, M. (1996) "MIRDOSE: the personal computer software for use in internal dose assessment in nuclear medicine", Journal of Nuclear Medicine 37, 538-546.
  • Emami, B., Lyman, J., Brown, A., Cola, L., Goitein, M., Munzenrider, J., Shank, B., Solin, L. and Wesson, M. (1991) "Tolerance of normal tissue to therapeutic irradiation", International Journal of Radiation, Oncology. Biology and Physics 21, 109-122.
  • Cohen, E., Lawton, C. and Moulder, J. (1995) "Bone marrow transplant nephropathy: radiation nephritis revisited", Nephron 70, 217-222.
  • Nourigat, C., Badger, C. and Bernstein, I. (1990) "Treatment of lymphoma with radiolabeled antibody: elimination of tumor cells lacking target antigen", Journal of the National Cancer Institute 82, 47-50.
  • Reske, S., Bunjes, D., Buchmann, I., Seitz, U., Glatting, G., Neumaier, B., Kotzerke, J., Buck, A., Martin, H. and Bergmann, L. (2001) "Targeted bone marrow irradiation in the conditioning of high-risk leukemia prior to stem cell transplantation", European Journal of Nuclear Medicine 28, 807-815.
  • O'Donoghue, J. (2000) "Optimal therapeutic strategies for radioimmunotherapy", In: Abramsand, P. and Fritzberg, A., eds. Systemic Radiotherapy with Monoclonal Antibodies (Marcel Decker, USA), pp. 1-20.
  • O'Donoghue, J. (1996) "Dosimetric principles of targeted radiotherapy", In: Sautter-Bihl, M.-L., Bihl, H. and Wannenmacher, M., eds, Radioimmuotherapy of Cancer (Springer, Berlin), pp. 77-100.
  • Horowitz, M., Gale, R., Sondel, P., Goldman, J., Kersey, J., Kolb, H., Rimm, A., Ringden, O. Rozman, C. Speck, B., Truitt, R., Zwaan, F. and Bortin, M. (1990) "Graft-versus-leukemia reactions after bone marrow transplantation", Blood 75, 555-562.
  • Marmont, A., Horowit, M., Gale, R., Sobocinski, K., Ash, R., Van Bekkum, D., Champlin, R., Dicke, K., Goldman, J., Good, R., Herzig, R., Hong, R., Masaoka, T., Rimm, A., Ringden, O., Speck, B., Weiner, R. and Bortin, M. (1991) "T-cell depletion of HLA-identical transplants in leukemia", Blood 78, 2120-2130.
  • Sullivan, K., Weiden, P., Storb, R., Witherspoon, R., Fefer, A., Fisher, L., Buckner, C., Anasetti, C., Appelbaum, F., Badger, C., Beatty, P., Bensinger, W., Berenson, R., Bigelow, C., Cheever, M., Clift, R., Deeg, H., Doney, K., Greenberg, P., Hansen, J., Hill, R., Loughran, T., Martin, H. Neiman, H., Petersen, F., Sanders, J., Singer, J. and Thomas, E. (1989) "Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia", Blood 13, 1720-1728.
  • Frassoni, F., Labopin, M., Gluckman, E., Prentice, H., Vemant, J., Zwaan, F., Granena, A., Gahrton, G., De Witte, T., Gratwohl, A., Reiffers, J. and Gorin, N. (1996) "Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time -- a report of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)", Bone Marrow Transplantation 17, 13-18.
  • Appelbaum, F. (2001) "Immunologic approaches to the treatment of acute myeloid leukemia", Hematology 2001, 73-77.
  • Ruffner, K. and Matthews, D. (2000) "Current uses of monoclonal antibodies in the treatment of acute leukemia", Seminars in Oncology 27, 531-539.
  • Bensinger, W., Martin, P., Storer, B., Clift, R., Forman, S., Negrin, R., Kashyap, A., Flowers, M., Lilleby, K., Chauncey, T, Storb, R. and Appelbaum, F. (2001) "Transplantation of bone marrow as compared with peripheral blood cells from HLA-identical relatives in patients with hematologie cancers", New England Journal of Medicine 344, 175-181.
  • Champlin, R., Schmitz, N., Horowitz, M., Chapuis, B., Chopra, R., Cornelissen, J., Gale, R., Goldman, J., Loberitza, F., Hertenstein, B., Klein, J., Montserrat, E., Zhang, M.-J., Ringden, O., Tomany, S., Rowlings, P., Van Hoef, M. and Gratwohl, A. (2000) "Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation", Blood 95, 3702-3709.
  • Sierra, J., Storer, B., Hansen, J., Bjerke, J., Martin, P., Petersdorf, E., Appelbaum, F., Bryant, F., Chauncey, T., Sale, G., Sanders, J., Storb, R., Sullivan, K. and Anasetti, C. (1997) "Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose", Blood 89, 4226-4235.
  • Sierra, J., Storer, B., Hansen, J., Martin, P., Petersdorf, E., Woolfrey, A., Matthews, D., Sanders, J., Storb, R., Appelbaum, F. and Anasetti, C. (2000) "Unrelated donor marrow transplantation for acute myeloid leukemia: an update of the Seattle experience", Bone Marrow Transplantation 26, 397-404.
  • Behr, T., Sharkey, R., Sgouros, G., Blumenthal, R., Dunn, R., Kolben, K., Griffiths, G., Siegel, J., Becker, W. and Goldenberg, D. (1997) "Overcoming the nephrotoxicity of radiometal-labeled immunoconjugates", Cancer 80(Suppl.), 2591-2610.
  • Cohen, E., Piering, W., Kabler-Babbit, C. and Moulder, J. (1998) "End-stage renal disease (ESRD) after bone marrow transplantation: poor survival compared to other causes of ESRD", Nephron 79, 408-412.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.